Show simple item record

dc.contributor.authorMa, Haiting
dc.contributor.authorWert, Katherine J.
dc.contributor.authorShvartsman, Dmitry
dc.contributor.authorMelton, Douglas A.
dc.contributor.authorJaenisch, Rudolf
dc.date.accessioned2018-10-12T19:10:46Z
dc.date.available2018-10-12T19:10:46Z
dc.date.issued2018-02
dc.date.submitted2017-02
dc.identifier.issn0027-8424
dc.identifier.issn1091-6490
dc.identifier.urihttp://hdl.handle.net/1721.1/118469
dc.description.abstractType 1 diabetes is characterized by autoimmune destruction of β cells located in pancreatic islets. However, tractable in vivo models of human pancreatic β cells have been limited. Here, we generated xenogeneic human pancreatic β-like cells in the mouse pancreas by orthotopic transplantation of stem cell-derived β (SC-β) cells into the pancreas of neonatal mice. The engrafted β-like cells expressed β cell transcription factors and markers associated with functional maturity. Engrafted human cells recruited mouse endothelial cells, suggesting functional integration. Human insulin was detected in the blood circulation of transplanted mice for months after transplantation and increased upon glucose stimulation. In addition to β-like cells, human cells expressing markers for other endocrine pancreas cell types, acinar cells, and pancreatic ductal cells were identified in the pancreata of transplanted mice, indicating that this approach allows studying other human pancreatic cell types in the mouse pancreas. Our results demonstrate that orthotopic transplantation of human SC-β cells into neonatal mice is an experimental platform that allows the generation of mice with human pancreatic β-like cells in the endogenous niche. Keywords: humanized mice; human pluripotent stem cells; beta cells; diabetesen_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant R01-CA084198)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant 5R01-MH104610-16)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant R01-GM114864)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant RF1-AG048029)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant U19- AI3115135)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant R37-HD045022)en_US
dc.description.sponsorshipEunice Kennedy Shriver National Institute of Child Health and Human Development (U.S.) (Grant R37-HD045022)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant 1R01-1NS088538-01)en_US
dc.description.sponsorshipNational Institute of Neurological Diseases and Stroke (U.S.) (Grant 1R01-1NS088538-01)en_US
dc.publisherNational Academy of Sciences (U.S.)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1073/PNAS.1702059115en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePNASen_US
dc.titleEstablishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreasen_US
dc.typeArticleen_US
dc.identifier.citationMa, Haiting et al. “Establishment of Human Pluripotent Stem Cell-Derived Pancreatic β-Like Cells in the Mouse Pancreas.” Proceedings of the National Academy of Sciences 115, 15 (March 2018): 3924–3929 © 2018 National Academy of Sciencesen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.mitauthorJaenisch, Rudolf
dc.relation.journalProceedings of the National Academy of Sciencesen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-09-26T12:26:25Z
dspace.orderedauthorsMa, Haiting; Wert, Katherine J.; Shvartsman, Dmitry; Melton, Douglas A.; Jaenisch, Rudolfen_US
dspace.embargo.termsNen_US
mit.licensePUBLISHER_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record